Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from EchoIQ Limited ( (AU:EIQ) ) is now available.
EchoIQ Limited has disclosed a change in director Steve Formica’s indirect interests, reflecting the conversion of performance rights into fully paid ordinary shares. Formica, through related party entities, increased his indirect holding by 625,000 shares while an equivalent number of Class E performance rights were cancelled following vesting conditions being met.
Following the transaction, Formica now indirectly holds 28,350,000 fully paid ordinary shares, alongside existing unlisted options and remaining performance rights. The change underscores confidence linked to EchoIQ’s share price performance, as the vesting was triggered by the company’s 20-day volume-weighted average price reaching a specified threshold, modestly tightening alignment between director incentives and shareholder value.
The most recent analyst rating on (AU:EIQ) stock is a Hold with a A$0.57 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.
More about EchoIQ Limited
EchoIQ Limited operates in the medical technology sector, focusing on cardiovascular diagnostics supported by artificial intelligence and data-driven tools. The company targets clinicians and healthcare providers by enhancing the detection and management of heart conditions through advanced imaging and analytical solutions.
Average Trading Volume: 2,286,995
Technical Sentiment Signal: Buy
Current Market Cap: A$385.7M
Find detailed analytics on EIQ stock on TipRanks’ Stock Analysis page.